Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITIES (Tables)

v3.24.1.1.u2
DERIVATIVE LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF CHANGES IN THE FAIR VALUE OF COMPANY'S LEVEL 3 FINANCIAL INSTRUMENTS

Changes in the fair value of the Company’s financial instruments for the nine months ended March 31, 2024 and 2023 were as follows:

  

    Level 1     Level 3     Level 3        
   

IPO and Rep

Warrants

   

Debenture

Warrants

   

Debenture

Convertible

Feature

    Total  
Balance at January 1, 2024   $ 11,308     $ 955,000     $ 1,724,000     $ 2,690,308  
Additions     -       564,000       359,000       923,000  
Conversions     -       -       (630,106 )     (630,106 )
Change in fair value     17,273       (736,181 )     742,677       23,769  
Effect of exchange rate changes     (285 )     (23,819 )     (43,571 )     (67,675 )
Balance at March 31, 2024   $ 28,296     $ 759,000     $ 2,152,000     $ 2,939,296  

 

    Level 1     Level 3     Level 3        
   

IPO and Rep

Warrants

   

Debenture

Warrants

   

Debenture

Convertible

Feature

    Total  
Balance at January 1, 2023   $ 275,115     $ 2,917,000     $ 1,457,000     $ 4,649,115  
Additions     -       2,378,000       1,599,000       3,977,000  
Conversions     -               (111,597 )     (111,597 )
Change in fair value     107,159       (2,930,015 )     (551,176 )     (3,374,032 )
Effect of exchange rate changes     1,402       (55,985 )     (19,227 )     (73,810 )
Balance at March 31, 2023   $ 383,676     $ 2,309,000     $ 2,374,000     $ 5,066,676